Daily Supplementation With Egg, Cow Milk, and Multiple Micronutrients Increases Linear Growth of Young Children with Short Stature by Mahfuz, Mustafa et al.
The Journal of Nutrition
Community and International Nutrition
See corresponding commentary on page 190.
Daily Supplementation With Egg, Cow Milk,
and Multiple Micronutrients Increases Linear
Growth of Young Children with Short Stature
Mustafa Mahfuz,1,2 Mohammed Ashraful Alam,1 Subhasish Das,1 Shah Mohammad Fahim,1
Md Shabab Hossain,1 William A Petri Jr,3 Per Ashorn,2 Ulla Ashorn,2 and Tahmeed Ahmed1
1icddr,b, Dhaka, Bangladesh; 2Faculty of Medicine and Life Sciences, University of Tampere, Finland; and 3University of Virginia,
Charlottesville, VA, USA
ABSTRACT
Background: Childhood stunting is the most prevalent public health nutrition problem in low- and middle-income
countries.
Objective: This study aimed to determine whether daily supplementation in 12–18-mo-old undernourished Bangladeshi
children with egg, cow milk, and multiple micronutrients improves linear growth.
Methods: In the Bangladesh Environmental Enteric Dysfunction (BEED) study, a community-based intervention study,
12–18-mo-old children with length-for-age z score (LAZ) <1 were supplemented daily with an egg and 150 mL of milk for
90 feeding days, and 1 sachet of multiple micronutrient powder was provided daily for 60 feeding days. The change in LAZ
over this period was compared with that in children of the same age and same baseline LAZ who were enrolled in the
recently completed Etiology, Risk Factors, and Interactions of Enteric Infections and Malnutrition and the Consequences
for Child Health (MAL-ED) Dhaka birth cohort study conducted in the same community where no nutrition intervention
was provided. Difference-in-difference (DID) analysis was done and the effect size was adjusted for other possible
covariates using a generalized estimating equation in a regression model.
Results: A total of 472 children with LAZ <1 completed the intervention and data were available for 174 children in
the comparison group. Compared with the comparison group, adjusted DID analysis revealed a change in LAZ in the
intervention group of +0.23 (95% CI: 0.18, 0.29; P < 0.05). In a subgroup analysis, the changes were +0.27 (95% CI:
0.18, 0.35; P < 0.05) in stunted (LAZ <2) children and +0.19 (95% CI: 0.12, 0.27; P < 0.05) in children at risk of stunting
(LAZ −1 to −2). No allergic reactions or other adverse events related to milk and egg consumption were observed.
Conclusions:Daily directly observedmilk, egg, andmultiplemicronutrient supplementationmay improve linear growth
of stunted children. A randomized controlled trial with longer duration of supplementation coupled with an additional
intervention aimed at reducing pathogen burden is warranted to confirm these results. This trial was registered at
clinicaltrials.gov as NCT02812615. J Nutr 2020;150:394–403.
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Introduction
Stunting [length-for-age z score (LAZ) <2 of the WHO
growth standard] (1) is currently the most common form of
childhood malnutrition worldwide (2). Stunting was found to
be associated with negative health and economic outcomes in
later life, including shorter adult height, impaired cognitive
development, lower attained schooling, and reduced adult
income (3). Together with low birth weight, stunting was
responsible for 2.1 million deaths and 91.0 million disabilty-
adjusted life years in 2008 (4). Globally, 151 million (22%)
children aged <5 y are stunted (5), while in Bangladesh, this
proportion was 36% in 2014 (6). Despite being a relatively
neglected area of research for many years, stunting has become a
major public health priority as the World Health Assembly has
called for reducing stunting by 40% between 2012 and 2025
(7).
Stunting is believed to be a result of interplay between
multiple causal and contextual factors in resource-poor settings,
and has been associated with increased susceptibility to
infection and impaired neurocognitive development (8). In
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affected children, such growth faltering usually manifests as a
steady decline in LAZ between the ages of 6 and 24 mo (9,
10). During this period, the child transitions from predominant
breastfeeding to complementary foods that are often deficient
in key macro-/micronutrients and low in diversity, while
diarrheal disease and exposure to enteropathogens is common
(5, 11, 12).
A recent analysis including data from 110 countries showed
that the average annual relative reduction in the rate of
childhood stunting is 1.8% per year (13). This is far behind
the rate of 3.9% that is required to meet the global target set
by the World Health Assembly to cut the number of children
with stunting to 100 million (7). Despite potential contributions
to reductions in morbidity and mortality, no single intervention
has demonstrated substantial efficacy in normalizing the linear
growth velocity and reversing the consequences of stunting.
Based on an assessment of multiple approaches to combat
stunting, it has been suggested that scaling up of nutrition-
specific interventions might correct about 20% of stunting
(5). Given that stunting is a consequence of exposure to a
complex mix of insults over time, successful treatment is likely
to require addressing the problems of consumption of low-
quality/diversity diets and recurrent pathogenic and adverse
environmental exposures (14).
Micronutrient deficiencies are an important determinant
of childhood undernutrition (8). Cereal-based diets of young
infants in developing countries lack essential micronutrients
such as zinc, vitamin A, and iron (12). In Bangladesh,
micronutrient adequacy is poor and a national survey showed
that 33% of children aged <5 y were anemic, 20.5% had
vitamin A deficiency, and 44.6% had zinc deficiency (15, 16).
Dietary supplementation with multiple micronutrient powder
was effective in controlling anemia and other micronutrient
deficiencies (17). In Bangladesh, the current recommendation
as per the National Strategy for Prevention and Control of
Anaemia is to provide a 5 component (zinc, iron, folic acid,
vitamin A, and vitamin C) multiple micronutrient powder for
2 mo (18).
A recent study revealed that daily provision of a chicken
egg can improve linear growth of young children and reduce
stunting (19). Egg is a good source of protein, fatty acids, and a
range of vitamins and minerals (20). Cow milk is a good source
of essential nutrients and its consumption is associated with
increased circulating insulin-like growth factor (IGF-1) that
promotes linear growth of children (21, 22). Both egg and milk
are culturally acceptable and locally available in Bangladesh.
Here, we used data from the Bangladesh Environmental
Enteric Dysfunction (BEED) study to explore whether daily
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supplementation with a chicken egg and 150 mL of cow milk
and essential micronutrients could improve linear growth of 12–
18-mo-old Bangladeshi children who were already stunted, or
who were at risk for stunting (23).
Methods
Study design
This is a community-based nonrandomized comparative intervention
study which is a part of the ongoing BEED study with a historical
comparison group from the recently completed Etiology, Risk Factors,
and Interactions of Enteric Infections and Malnutrition and the
Consequences for Child Health (MAL-ED) study (23, 24).
Description of parent studies.
Intervention group. In the BEED study, children aged 12–18 mo
with LAZ <1 were enrolled from the study area through community
screening. The first child was enrolled in July 16, 2016 and children
enrolled until June 30, 2018 were included in the current analysis. After
enrollment, the children were provided with directly observed nutrition
intervention for 90 feeding d (23).
The inclusion criteria for enrollment in the BEED study include
children of either gender, aged between 12 and 18 mo, LAZ <1, and
parent(s) or caregivers willing to sign the consent form and bring the
child to the study site every day, 6 d/wk, for 90 d of nutritional therapy.
Children with severe acute malnutrition, severe anemia (<8 g/dL),
tuberculosis, other chronic diseases or any congenital disorder or
deformity, an ongoing episode of diarrhea, a history of persistent
diarrhea in the past month, or known allergy/intolerance to eggs or milk
were excluded (23).
Comparison group. The MAL-ED Bangladesh study was an
observational birth cohort study in which infants were enrolled within
3.5 d of birth and followed longitudinally until age 60 mo without
any nutrition intervention (24). Data used in the current analysis were
collected between June 11, 2011 and September 15, 2013, covering
the period in which included children were aged between 14 mo and
17 mo. During the first 24 mo of the study, the children were followed
by twice weekly home visits for dietary and morbidity surveillance.
Anthropometry was collected monthly from all participants, while data
on sociodemography and food security were collected during enrolment
and at 6-mo intervals. The detailed methodology of data collection is
described elsewhere (25–27).
The inclusion criteria for enrollment in the MAL-ED study were
healthy newborn children of either gender, and parent(s) or caregivers
willing to sign the consent form and have a plan to stay in the
community for the next 2 y. Exclusion criteria were very low birth
weight (<1500 g), extremely ill, severe acute malnutrition, severe
anemia (<8 g/dL), tuberculosis, other chronic diseases or any congenital
disorder or deformity, nonsingleton infant and mother aged <16 y
(24–27).
Study settings.
Description of field site. Both BEED and MAL-ED studies were
conducted among the residents of Bauniabadh and adjacent slum areas
of Mirpur, Dhaka. The population density of the area is one of the
highest in Dhaka city, with more than 38,000 people living in each
square kilometer. The sociodemographic details of the field site have
already been reported (23, 24).
Participants.
Intervention groups. Children aged 12–18mowere enrolled from
the study area with a LAZ of <1. This child cohort was further divided
into 2 groups: stunted children (LAZ< −2) and children at risk of being
stunted (LAZ <1 to −2).
Egg and milk to improve linear growth of children 395
D
ow
nloaded from
 https://academ
ic.oup.com
/jn/article-abstract/150/2/394/5607415 by Tam
pere U
niversity and U
niversity H
ospital user on 07 February 2020
TABLE 1 Nutrition and health intervention with delivery method provided to children of intervention group1
Intervention Delivery method
Egg − 1 boiled egg daily, 6 d/wk
Milk − UHT processed 150 mL whole milk daily, 6 d/wk
Multiple micronutrient powder − 1 sachet of multiple micronutrient powder a day administered to the child during each feeding session for 2 mo
− Each sachet contained 12.5 mg iron, 5 mg zinc, 300 μg vitamin A, 150 μg folic acid, and 50 mg of vitamin C (Monimix)
Nutritional counseling − Parents/caregivers were given nutritional counseling with particular emphasis on adding vegetable oil to the cooked diet as a source of
energy, as well as sources of animal-based products (small fish, chicken, or meat) along with regular intake of vegetables
1UHT, ultra-high temperature.
Comparison group. The median age of children in the inter-
vention group at baseline was 14 mo. The MAL-ED study was a
longitudinal birth cohort with monthly follow-up data available for all
children. We extracted data from MAL-ED children with LAZ <1 at
14 mo and follow-up growth data were collected for the subsequent
4 mo (14–18 mo). The comparison group was matched with the
intervention group for age and LAZ. In addition, the following features
were comparable between the groups: sex, community information,
similar frequency of contact with research staff, anthropometry
measurement using the same scales, and follow-up performed by the
same research team.
Intervention group.
Enrollment, screening, and consenting. Census, screening, and
enrollment of the subjects was conducted in the Mirpur area of
Dhaka city through household visits. Based on predefined inclusion
criteria, field research assistants enrolled the children whose parent(s) or
caregivers were willing to consent and bring their child to the nutrition
center every day for 90 feeding d to receive nutritional therapy. Parents
of the children who met the eligibility criteria were invited to participate
and the study was explained to them in detail by a trained research staff.
A written informed consent was signed by the mother or the primary
caregiver of the participants before enrollment in the study (23).
Detailed procedure of directly observed nutritional therapy.
After enrollment, participants were asked to attend the designated
nutrition center (established in the Bauniabadh area, Mirpur) daily for
nutritional therapy between 10:00 and 11:30 for 90 feeding d to avoid
the issue of food sharing at home. The consumption of milk and egg
was directly observed by the field staff. Before serving, each shell-less
boiled egg was weighed and 150 mL of milk was measured and the total
amounts of food offered, consumed, and left over were measured and
recorded at each feeding session. One sachet of multiple micronutrient
powder (Monimix, Renata Pharmaceuticals) was mixed with milk by
1 of the research staff during daily feeding for 2 mo. This food
was given in addition to the regular diet, and the mothers were
instructed to continue usual feeding including breastfeeding. The
intervention provided in the study was free of cost. In addition to this
feeding intervention, caregivers were provided nutritional counseling
during each of the feeding session. Nutritional counseling sessions
were conducted using communication materials including posters,
pictures, and pamphlets. They discussed how to provide a balanced
diet, dietary diversity, minimum meal frequency, importance of animal
source protein and iodized salt, water-sanitation-hygiene practice, etc.
Details of the nutrition intervention are described in Table 1 and the
composition of the supplemental meal is described in Table 2. The
nutrition intervention started on July 25, 2016 and this analysis includes
all the children in the BEED study who completed nutrition intervention
by June 30, 2018 (n = 472).
This directly observed nutrition intervention was provided for 90
feeding d, 6 d/wk, except for the weekends. Furthermore, some children
were followed for >108 d who missed or were reluctant to take the
intervention on scheduled feeding d. However, a child was discontinued
from the study and referred for medical evaluation if he/she did not
take at least 50% of the food offered for 7 consecutive d (23).
Primary outcome.
The primary outcome of this analysis was the change in LAZ
of intervention group compared to children in comparison group,
conducted in the same settings in Bangladesh.
TABLE 2 Characteristics of the children at baseline in intervention and comparison groups1
Indicators Intervention (n= 472) Comparison (n= 174) P value2
Age, mo 14 [13, 16] 14 [14, 14] 0.37
Female 236 (50) 90 (51.72) 0.69
Currently breastfeeding 431 (91.31) 168 (96.55) 0.02
WAMI index 0.58 ± 0.14 0.52 ± 0.12 <0.001
Improved sanitation 297 (62.92) 174 (100) <0.001
Improved source of drinking water 472 (100) 174 (100) NA
Maternal education, y 5 [2, 7] 5 [2, 7] 0.44
Length-for-age z score at baseline −2.15 ± 0.80 −2.10 ± 0.75 0.48
Weight-for-age z score at baseline −1.71 ± 0.85 −1.65 ± 0.82 0.06
Weight-for-length z score at baseline −0.90 ± 0.87 −0.76 ± 0.94 0.07
Income, US$/mo 157 [124, 241] 97 [72, 133] <0.001
Maternal height, cm 149.26 ± 5.21 148.52 ± 5.23 0.11
Stool α1-antitrypsin, mg/g 0.30 [0.12, 0.57] 0.42 [0.24, 0.66] <0.001
Stool myeloperoxidase, ng/mL 2300 [1340, 4380] 5250 [3030, 10,800] <0.001
Stool neopterin, nmol/L 2480 [1270, 3790] 1380 [714, 2190] <0.001
1Values are means ± SDs, median [IQR], or frequency (percentage). WAMI index, Water-sanitation-hygiene, Asset status, Maternal
education status, and monthly Income index.
2Student’s t test, Pearson chi-square test, and Mann-Whitney U test, as appropriate.
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Data collection, management, and storage.
Data collection tools for this study included case report forms. All the
forms were de-identified by coded numbers to maintain participants’
confidentiality and to enable tracking throughout the study.
Anthropometry was performed bi-weekly in the intervention group
and monthly in the comparison group. To make the groups comparable,
we used anthropometry data of the intervention group collected every
28 d. Because children in the intervention group were followed for
a median of 108 d to complete 90 d of feeding, anthropometric
measurements at 5 time points were available for this analysis.
Anthropometric data were collected by trained personnel, through
use of scales with high precision. Weight was measured with a Seca
digital weighing scale (model 727, Hamburg, Germany) and length
was measured with a Seca infantometer (model 416, Seca, Hamburg,
Germany). The same weight and length measurement scales were used
for both the intervention and comparison groups (23, 24).
In both groups, socioeconomic and demographic data, maternal in-
formation, and maternal anthropometry data were collected at baseline.
Tomeasure and compare socioeconomic status between the intervention
and control groups, we used the composite Water-sanitation-hygiene,
Asset status, Maternal education status, and monthly Income index.
This index was used in the MAL-ED study and details have been
reported elsewhere (28).
The food intake and compliance data for the nutritional intervention
(including data on breastfeeding) were collected daily throughout the
intervention period (23).A quantitative 24-h recall approach to estimate
nutrient and energy intakes from nonbreast milk complementary foods
was carried out before and during intervention in a subset of children
(n = 45). Dietary assessments by 24-h recall were performed twice:
before onset of intervention and during intervention. Experienced
research staff who were trained by experienced dieticians conducted the
dietary assessments. To assist mothers to provide precise quantification
of food intake by their children in the last 24 h, standardized measuring
utensils and picture of foods with different portion sizes were used.
These interviews were conducted without prior notification to mothers.
The methods we used have been published elsewhere (15).
Reported daily morbidity data were available for both the
intervention and comparison groups.Diarrhea was defined as passage of
≥3 loose stools in 24 h, and fever was defined as an axillary temperature
of >99◦F (37.2◦C) by a mercury thermometer. In the intervention
group, morbidity data were collected during daily feeding sessions, and
in the comparison group, the morbidity data were collected through
twice-weekly home visits (24). As a measure of environmental enteric
dysfunction (EED), stool neopterin (GenWay Biotech),myeloperoxidase
(Alpco), and α-1 antitrypsin (Biovendor) were assayed with use
of commercial ELISA kits. The laboratory methodologies for the
assays have already been published (29, 30). In this paper, we used
baseline biomarker results for both the intervention and comparison
groups.
Quality control of anthropometric data and refresher
training.
Anthropometric measurements were conducted by trained field staff
following established standard operating procedures. To maintain the
precision of the measurements, 5% of the participants were measured a
second time within 24 h of each data collection. The measuring equip-
ment was calibrated daily according to the manufacturers’ instructions.
To ensure the consistency of an anthropometric measurement from
1 rater to another, refresher training was provided on a regular basis to
the field staff and the intra-class correlation coefficient was determined
every 3 mo. Such training resulted in significant improvement of raters
pertaining to anthropometric measurements with a coefficient >0.9 for
each of the scales.
Data analysis
Statistical analyses were performed using STATA (Version 13.1,
StataCorp). Statistical significance was defined as P < 0.05. The
distribution of LAZ was checked for normality with a histogram,
QQ plot, and tests for kurtosis and skewness. We compared baseline
characteristics between intervention groups and comparison group
using Student’s t tests, Pearson chi-square tests, and Mann-Whitney U
tests, as appropriate. Both parametric and nonparametric approaches
were used for analyses and reported as medians and IQR, or mean and
SD (31).
Standard biostatistical modeling techniques were used, including
review and stabilization of the variance of the outcome distributions,
identification of outliers, and inclusion of confounders in the models.
Anthropometry data were collected at 5 time points: at baseline before
the beginning of the intervention, at time-1, at time-2, at time-3, and
after completion of the intervention. The comparison group data were
collected every 30 d and the intervention group data were collected
every 28 d. The change in LAZ before and after the interventions was
compared within each group and between the groups. The difference-
in-difference (DID) analysis technique, a quasi-experimental design
that uses data from intervention and control groups to make a
counterfactual to estimate the intervention effect, was used to measure
the true effect of nutritional intervention on LAZ with the following
formula:
DID : [(B − A) − (D − C)] (1)
where, A= baseline mean LAZ of intervention group, B= endline mean
LAZ of intervention group, C = baseline mean LAZ of comparison
group, and D = endline mean LAZ of comparison group.
To assess the true effect of nutritional intervention, we used a
regression model with a generalized estimating equation as follows:
Yit = β0 + β1Time + β2Group + δ (Time × Group) + β3X + ε (2)
where, Yit = outcome variable of interest for individual i at time t,
Time = (1) if endline and (0) if baseline, Group = (1) if intervention
group and (0) if comparison group, δ = the effect of nutritional
intervention, X = other covariates, and ε = error term.
An additional analysis was done similarly where BEED stunted
children were compared with MAL-ED stunted children, and BEED
at risk of stunting children were compared with MAL-ED at risk of
stunting children.
For dietary assessment, 24-h dietary recall data were converted
to nutrients using available food composition tables. Details on these
food composition tables have been published elsewhere (15). We have
calculated nutrient adequacy ratio, which is the ratio of average
daily intake and the RDA (15). We used the age-specific RDA from
the recommendation developed by the Institute of Medicine, USA
(32, 33). We have reported consumption of energy and nutrients
as the percentage of RDA, which is also the percentage of nutrient
adequacy ratio. Differences between energy and nutrient intakes before
and during intervention were tested with use of a sign test, and
differences between energy and nutrient intakes between breastfed and
nonbreastfed children were tested with a Mann-Whitney U test.
Ethical approval
Ethical approvals was obtained from the Institutional Review
Board of icddr,b (protocol no: PR-16,007; Version 1.03; March 1,
2016).
Results
A total of 1287 children with LAZ <1 were screened for BEED,
of which 616 children were stunted and 670 children were
at risk of stunting. A total of 761 children did not meet the
inclusion/exclusion criteria and 525 children were enrolled in
the study.Among 761 children whowere screened out following
exclusion criteria, 74% of parents did not sign the consent,
18% of children had severe anemia (Hb <8 g/dL), 5% of
children were suffering from illness, and 3% had developmental
delays or congenital anomalies. The parents did not sign the
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Screened
1287
Screen out
Enrolled: 525
Stunted: 249
At risk of stunting: 
276
After intervention
Total: 472
Stunted: 220
At risk of stunting: 252
Discontinued: 52
Migrated to different 
community: 45
Parents decided to 
discontinue: 7 
(maternal illness, 
afraid of blood 
collection, second 
marriage of father)
Stunted, LAZ <-2
616
At risk of stunting
LAZ (-1 to -2)
670
Stunted = 367
At risk of stunting = 394
Intervention group
BEED study
Children 12-18 mo, LAZ <-1
Intervention
Daily 1 egg
150 mL milk
1 sachet MNP
90 feeding d
Comparison group
MAL-ED study
Children 14 mo, LAZ <-1
Healthy Newborn
Enrolled after 
birth: 265
Continued follow-up 
till 14 mo: 226
Continued follow-up 
till 17 mo: 216
LAZ <-1: 174
Stunted: 82
At risk of stunting: 92
LAZ >-1: 42
F
ollow
ed tw
ice w
eekly, 
anthropom
etry m
onthly
First participant 
enrolled
16 July 2016
Last participant 
intervention complete
30 June 2018
First participant 
enrolled
11 February 2010
First participant 
reached 14 mo
11 June 2011
Last participant 
complete 17 mo
15 Sept 2013
FIGURE 1 Flow diagram of study. BEED, Bangladesh Environmental Enteric Dysfunction study; LAZ, length-for-age z score; MAL-ED, Etiology,
Risk Factors, and Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health; MNP, micronutrient powder.
consent forms for the following reasons: 129 simply refused
to enroll their children, 259 refused to provide blood samples,
152 had plans to migrate out from the community, and 3 were
working parents. Complete data were available for 472 children
(220 stunted children and 252 children at risk of stunting).
Fifty-two participants failed to complete the intervention. Of
these, 45 migrated out from the community with their family
and 7 were withdrawn from the study by their parents for
other reasons.The comparison group had complete data for 209
children, collected between the ages of 14 mo to 17 mo of which
174 children had LAZ <1. The enrollment scheme is shown in
Figure 1.
At baseline, the median age of children from both groups
was 14 mo, and baseline anthropometry including LAZ was
comparable between intervention and comparison groups.
Stool α-1 antitrypsin and myeloperoxidase concentrations
were significantly higher in comparison children compared to
intervention, and concentration of neopterin was higher in
intervention children than the children from comparison group.
Baseline characteristics are described in Table 2.
To achieve directly observed nutrition intervention in the
nutrition centers for 90 feeding d, the children were followed for
a median (IQR) of 108 (106, 112) d. The average (mean ± SD)
number of visits to the nutrition centers made by the stunted
children was 89.9 ± 0.18 d, and for the at risk children, it
was 86.8 ± 1.2 d. Children were offered daily a boiled egg
with a mean (SD) shell-less weight of 56.4 ± 0.9 g and the
average egg consumptions of the stunted and at risk of stunting
children were 54.7 ± 2.9 g and 54.9 ± 2.9 g, respectively.
Compliance of egg consumption was 97% and compliance of
milk consumption was 99% for both the groups (Table 3).
Table 4 describes the energy and nutrients provided by each
component of the nutritional intervention and the percentage
of the RDA provided by the intervention for this age group
(32, 33).One egg, 150mL of milk, and 1 sachet of micronutrient
powder provided 33% of the required kcal of energy, 92%RDA
of protein, 6% RDA of carbohydrate, 40% RDA of calcium,
188% RDA of iron, and 206% RDA of zinc.
We also collected quantitative dietary intake data of the
children before and during nutrition intervention using the
24-h dietary recall approach (Table 5). We observed that
before intervention the dietary intakes for energy, protein,
carbohydrate, vitamins,minerals, and trace elements were much
lower than the age-specific RDAs. On the other hand, dietary
intake data collected during nutrition intervention showed a
marked improvement of intakes for energy, protein, iron, zinc,
vitamins, and other trace elements (Table 5). At baseline, before
the start of the intervention, 91% of children were breastfed,
and at the end of intervention, still 88% children continued to
breastfeed (Supplemental Table 1). We also compared nutrient
intakes between the breastfed and nonbreastfed children.
TABLE 3 Compliance of daily milk and egg consumption in
children of intervention group1
Indicators Values (n = 472)
Egg offered, g 56.4 ± 0.96
Egg consumed, g 54.8 ± 2.95
Egg consumption compliance, %2 97.2 ± 4.78
Milk offered, mL 150 ± 0
Milk consumed, mL 148 ± 2.78
Milk consumption compliance, %2 98.8 ± 1.86
1All values are means ± SDs.
2Percentage of egg or milk consumption compliance calculated by
[(consumed/offered) × 100].
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TABLE 4 Nutritional content and estimated percentage of RDA of each component of nutrition intervention provided to the children
of the intervention group1
RDA Egg (56 g) Milk (150 g) MNP (1 g) Total intake % of RDA
Energy, kcal/d 548 86.8 92.6 0.00 179 32.7
Protein, g/d 13 7.04 4.97 0.00 12.0 92.4
Fat, g/d ND 5.94 5.02 0.00 10.9 —
Carbohydrate, g/d 130 0.63 6.98 0.00 7.60 5.85
Calcium, mg/d 500 28.0 175 0.00 203 40.6
Iron, mg/d 7 0.67 0.05 12.5 13.2 189
Zinc, mg/d 3 0.59 0.62 5.00 6.21 207
Copper, mg/d 0.34 0.01 0.02 0.00 0.03 7.50
Vitamin C, mg/d 15 0.00 0.00 30.0 30.0 200
Thiamin, mg/d 0.5 0.04 0.06 0.00 0.10 19.6
Riboflavin, mg/d 0.5 0.29 0.28 0.00 0.57 114
Niacin, mg/d 6 0.04 0.17 0.00 0.20 3.35
Vitamin B-6, mg/d 0.5 0.07 0.05 0.00 0.12 23.6
Folate, μg/d 150 24.6 6.56 160 191 128
Vitamin B-12, μg/d 0.9 0.62 0.54 0.00 1.16 129
Vitamin A, μg/d 300 94.6 43.2 300 438 146
Vitamin E, mg/d 6 0.58 0.09 0.00 0.67 11.2
1MNP, micronutrient powder; ND, no available data. RDA is the average daily dietary intake amount, sufficient to meet the nutrient requirements of nearly 97–98% healthy
individuals in a group (32, 33).
Energy intake and carbohydrate consumption were significantly
higher in nonbreastfed children than the breastfed children. All
other estimated nutrients were comparable between the groups
(Supplemental Table 2).
The mean LAZ of children in the intervention group
before, during, and after nutritional intervention in comparison
to children in the MAL-ED birth cohort for the same
duration are illustrated in Figure 2. After adjusting for baseline
LAZ, age, sex, mother’s height, diarrhea, fever, cough, use
of antibiotics, breastfeeding status, and the Water-sanitation-
hygiene, Asset status, Maternal education status, and monthly
Income index, in a multivariable regression model, DID analysis
showed a positive change in LAZ (intervention compared with
comparison: coefficient 0.23, 95% CI: 0.17, 0.28, P < 0.001)
(Table 6). After categorizing the children in the intervention
and comparison groups into those who were stunted and
at risk of stunting, a subgroup DID analysis was performed
between stunted children in the 2 groups and the children
at risk of stunting in both groups. This analysis yielded
similar results (stunted intervention compared with stunted
comparison: coefficient 0.27, 95% CI: 0.18, 0.35, P < 0.001; at
risk of stunting intervention compared with at risk of stunting
comparison: coefficient 0.19, 95% CI: 0.12, 0.27, P < 0.001)
(Table 7).
TABLE 5 Nutrient intake of children of intervention group before and during intervention estimated from quantitative 24-h recall
data1
Daily intake % of RDA
RDA
Before intervention
(n= 45)
During intervention
(n= 45) P value2
Before intervention
(n= 45)
During intervention
(n= 45) P value2
Energy, kcal/d 548 396 (43.6, 852) 636 (255, 1120) <0.001 72.2 (7.9, 155) 116 (46.5, 205) <0.001
Protein, g/d 13 11.0 (0.6, 32.8) 24.3 (5.7, 46.9) <0.001 84.8 (4.7, 252) 187 (44.0, 361) <0.001
Fat, g/d ND 9.7 (0.2, 36.7) 19.6 (5.7, 39.2) <0.001 — — —
Carbohydrate, g/d 130 56.7 (9.7, 182) 88.1 (36.9, 157) <0.001 43.6 (7.5, 140) 67.8 (28.4, 121) <0.001
Calcium, mg/d 500 65.6 (3.7, 645) 258 (23.0, 995) <0.001 13.1 (0.7, 129) 51.6 (4.61, 199) <0.001
Iron, mg/d 7 2.2 (0.12, 8.00) 15.3 (13.8, 19.8) <0.001 31.2 (1.8, 114) 219 (197, 283) <0.001
Zinc, mg/d 3 1.3 (0.1, 3.89) 7.69 (5.7, 9.5) <0.001 43.5 (2.7, 130) 256 (189, 316) <0.001
Copper, mg/d 0.34 0.26 (0.03, 0.6) 0.38 (0.1, 0.8) <0.001 77.4 (9.7, 201) 112 (32.5, 249) <0.001
Vitamin C, mg/d 15 6.9 (0.1, 78.2) 40.0 (30.0, 318) <0.001 46.3 (0.8, 521) 267 (200, 2120) <0.001
Thiamin, mg/d 0.5 0.17 (0.01, 0.8) 0.34 (0.1, 0.8) <0.001 34.9 (0.3, 154) 67.7 (27.2, 171) <0.001
Riboflavin, mg/d 0.5 0.31 (0.002, 1.5) 0.76 (0.1, 1.9) <0.001 61.5 (0.4, 298) 153 (28.8, 381) <0.001
Niacin, mg/d 6 3.46 (0.02, 9.8) 4.02 (0.5, 10.7) 0.016 57.6 (0.4, 164) 67.1 (8.04, 178) 0.016
Vitamin B-6, mg/d 0.5 0.4 (0.003, 0.9) 0.53 (0.2, 1.1) <0.001 74.4 (0.8, 176) 106 (33.9, 212) <0.001
Folate, μg/d 150 26.2 (0.3, 3) 225 (178, 378) <0.001 17.5 (0.2, 204) 150 (119, 252) <0.001
Vitamin B-12, μg/d 0.9 0.5 (0.00, 8.1) 1.49 (0.15, 5.5) <0.001 59.4 (0.0, 900) 166 (16.1, 608) <0.001
Vitamin A, μg/d 300 57.8 (0.4, 1820) 486 (307, 1380) <0.001 19.3 (0.1, 607) 162 (102, 461) <0.001
Vitamin E, mg/d 6 0.79 (0.005, 3.3) 1.30 (0.4, 7.06) <0.001 13.2 (0.07, 54.7) 21.7 (7.4, 118) <0.001
1All values are median (min, max). ND, no available data. (An RDA is the average daily dietary intake amount, sufficient to meet the nutrient requirements of nearly 97–98%
healthy individuals in a group) (32, 33).
2Sign test was performed to test statistical difference.
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Intervenon (n=472) 
Comparison (n=174) 
FIGURE 2 Length-for-age z score of children in intervention and comparison groups over study period with 95% CI. The comparison group
data were collected every 30 d and the intervention group data were collected every 28 d.
We did not observe any allergic reactions or other adverse
events related to milk and egg consumption.
Discussion
Our results indicate that stunted and at risk of stunting
children who underwent daily dietary supplementation with
150 mL of milk and 1 egg for 90 d and 1 RDA of multiple
micronutrient powder for 60 d had better length-for-age z
scores. We are not aware of any prior study in which stunted
children aged 12–18 mo were provided with egg, milk, and
multiple micronutrient powder for 90 d to examine changes in
LAZ. There are some studies involving intervention with egg,
milk, or multiple micronutrient powder alone, although the age
group and duration of interventionwere not similar to our study
(17, 19–22).
In the Lulun project, a randomized controlled trial conducted
in Ecuador, 80 infants aged 6–9 mo were provided with 1 egg/d
for 6 mo. Egg intervention increased LAZ by 0.63 compared to
the control group (19). This is the only published study in which
egg was given to young children to improve the linear growth.
The effect size for LAZ in the Ecuador trial was substantially
higher than any complementary feeding trial conducted earlier
(19); the systematic reviews reported earlier showed that the
experimental studies with supplementary foods for at least
6 mo among children aged <2 y in food insecure households
was associated with a significant improvement in LAZ (stan-
dardized mean difference 0.39; 95% CI: 0.05, 0.73) (34, 35). In
our study, we observed a positive change in LAZ of 0.24 (95%
CI: 0.19, 0.30) in children receiving intervention. It should also
be noted that we provided nutrition intervention for only 90 d,
every feeding session was directly observed and amounts of egg
and milk offered and consumed by children were measured and
recorded by research staff.
Egg is a nutritious food and an average 55 g egg contains
75 calories, 7 g protein, 5 g of fat, 1.6 g of saturated fat, vitamins,
minerals, and carotenoids (20). Choline, an important precursor
of phospholipid, abundant in eggs, is required for cell division
and growth (20, 36, 37). In children aged 7–12 mo, an average
50 g egg provides 57% of RDA of protein, 98% Adequate
Intake (AI) of choline, and 88% of AI of vitamin B-12, 25–50%
of AI for vitamin B-6, folate, phosphorus, and around 20%of AI
for zinc (20). In addition to its role in improving linear growth
of young children, studies have shown that egg supplementation
can improve choline and docosahexaenoic acid status, both
are important for growth and neurocognitive development
(20). Currently, there are no data on the acceptability of egg
in Bangladeshi children. In this study, we observed excellent
compliance with egg consumption among children and we did
not encounter families that were hesitant to feed their children
eggs.
Each 100 g of whole cow milk provides 64 kcal of
energy and 3.5 g of protein (21). It also contains important
micronutrients and bioactive components that likely contribute
to its effects on growth. Studies conducted in developing
countries have underscored the considerable benefits of cow
milk in stimulating linear growth (21). Observational studies
TABLE 6 DID analysis of LAZ scores between children in intervention and comparison groups1
n Intervention n Comparison DID P value2
Baseline 472 −2.15 (−2.22, −2.07) 174 −2.10 (−2.21, −1.98)
Endline 472 −2.06 (−2.13, −1.99) 174 −2.24 (−2.36, −2.12) 0.23 (0.18, 0.29) <0.001
1All values are mean difference (95% CI) or DID (95% CI). DID, difference-in-difference; LAZ, length-for-age z score; WAMI, Water-sanitation-hygiene, Asset status, Maternal
education status, and monthly Income index.
2Effect of intervention was adjusted for other possible covariates using generalized estimating equation. Adjusted covariates are: age, baseline LAZ, sex, breastfeeding status,
mother height, diarrhea, fever, cough, antibiotic use, myeloperoxidase, neopterin, α-1 antitrypsin, and WAMI index. Baseline: before intervention, endline: after completion of
intervention.
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TABLE 7 Subgroup analyses of stunted and at risk of stunting children in intervention and comparison groups to examine changes in
LAZ between the groups1
n Intervention n Comparison DID P value2
Stunted children Baseline 220 −2.82 (−2.90, −2.73) 82 −2.71 (−2.85, −2.58)
Endline 220 −2.68 (−2.76, −2.59) 82 −2.84 (−2.98, −2.71) 0.27 (0.18, 0.35) 0.0001
Children at risk of stunting Baseline 252 −1.56 (−1.59, −1.52) 92 −1.54 (−1.60, −1.49)
Endline 252 −1.52 (−1.57, −1.47) 92 −1.70 (−1.79, −1.61) 0.19 (0.12, 0.27) 0.0001
1All values are mean difference (95% CI) or DID (95% CI). DID, difference-in-difference; LAZ, length-for-age z score; WAMI, Water-sanitation-hygiene, Asset status, Maternal
education status, and monthly Income index.
2Effect of intervention was adjusted for other possible covariates using generalized estimating equation. Adjusted covariates are: age, baseline LAZ, sex, breastfeeding status,
mother’s height, diarrhea, fever, cough, antibiotic use, myeloperoxidase, neopterin, α-1 antitrypsin, and WAMI index. Baseline: before intervention, endline: after completion of
intervention.
have also demonstrated the growth-stimulating effect of milk
in a nutrient-adequate population (21). Growth hormone is
less important in early childhood, although its role in child
growth starts as early as age 9 mo (38). Growth hormone
and nutritional status regulate the synthesis of the insulin-
like growth factor-1 (IGF-1) in the liver. In a cohort of
stunted Zimbabwean children, amounts of IGF-1 were low and
negatively correlated with markers of systemic inflammation
(39). IGF-1 increases the uptake of amino acids which are
incorporated into new protein including in bone tissue, thereby
facilitating bone growth (21). IGF-1 is also involved in calcium
and phosphate homeostasis (40), playing an essential role in
bone remodeling (41). Hence, by increasing amounts of IGF-
1, consumption of cow milk is expected to lead to an increase
in linear growth velocity (22, 23).
Micronutrient deficiency, particularly iron, zinc, and vitamin
A deficiency, is common in children in developing countries
where growth faltering is also high. Zinc deficiency is associated
with childhood stunting and supplementation of multiple
micronutrient powder can reduce anemia and morbidity, and
improve nutritional status (42). In addition to milk and egg,
1 sachet of multiple micronutrient powder containing the
RDAs of vitamin A, vitamin C, folic acid, iron, and zinc
was provided daily for 2 mo during nutrition intervention.
The 24-h recall data indicate that intake of both macro-
and micronutrients were improved through the intervention
regimen.
Children in the comparison group from the MAL-ED study
exhibited gradually worsening LAZ scores between the ages
of 15 and 18 mo. The prevalence of stunting in the MAL-
ED birth cohort was 18% at 6 mo and increased to 48%
at 24 mo (27). In the absence of nutritional supplementation,
this is a typical pattern of linear growth faltering in young
children living in slum areas of Bangladesh. Nutritional
supplementation with milk, eggs, and multiple micronutrient
powder improved LAZ scores of children in the intervention
group. Despite the comparatively short duration of interven-
tion, this directly observed nutritional supplementation was
effective.
Postnatal growth is characterized by an increased linear
growth velocity that reduces gradually after birth. The velocity
of linear growth of a healthy child is approximately 25 cm per
year in the first year and 12 cm from 12 to 24 mo (43). This
means that between 12 and 18 mo, a healthy child is expected
to grow by 1 cm/mo. We observed that the mean ± SD length
increment for stunted and at risk of stunting children were
3.63 ± 0.87 cm and 3.54 ± 0.94 cm, respectively after 90 d
of intervention, a higher rate than that of healthy children. On
the other hand, during the first year of life, the length velocity
is 2.1 cm/mo; this might be the reason why the Lulun trial
observed a larger LAZ increase in children who were enrolled
at age 6–9 mo.
EED biomarkers between the intervention and comparison
groups showed mixed results. α-1 antitrypsin and myeloperoxi-
dase were higher in the comparison group, which means MAL-
ED children had more protein loss and intestinal inflammation
(30, 44). On the other hand, children in the intervention
group had higher concentrations of neopterin. Neopterin is
a biomarker of intestinal inflammation and cellular immune
activation (30, 44, 45). This also means that over the period of
time children in the slums were similarly exposed to pathogens
(46, 47).
The egg and milk supplementation provided here was
accepted by the children and mothers as judged by the low
dropout rates. There were no records of any adverse event,
including allergic reactions associated with egg and milk
consumption. There are limitations of this study. This was a
nonrandomized trial with the absence of concurrent control
group. Absence of randomization is prone to major biases and
also known to be associated with both overestimation and
underestimation of treatment effect (48, 49). The comparison
data from the MAL-ED study, collected 3 y before the current
study, can be a source of type 1 error and overestimation of
treatment effect (50). No nutritional counselling was provided
in the control group, thus preventing us from separating the
effect of behavior change from the nutritional intervention
itself. On the other hand, the duration of supplementation
was 90 feeding d, which may be too short to assess the full
potential of the intervention on linear growth. Moreover, we
did not measure amounts of IGF-1, which may have provided
insight regarding potential longer-term efficacy of treatment.
Dietary assessment done from a subsample of 45 children might
not be representative of all participants under intervention
and absence of data on energy and nutrient intakes from
breastfeeding is another limitation of this study. Considering
cost and complexity of this intervention, and also compared to
other research in the same area, the effect size seemed modest.
Therefore, justification of this intervention at the programmatic
level is subject to further investigation. The role of pathogen
burden and its association with childhood stunting observed in
the same population (27, 47) were also not addressed. Finally,
the inability to identify which of the 3 components of the
nutritional intervention was driving the change (or whether
all three are required) adds to the cost of the treatment,
which may in turn preclude its application in resource-limited
programs.
In resource-poor settings with poor maternal education level
and high burden of infectious morbidity, directly observed
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nutrition therapy with locally available and culturally accept-
able nutritious foods (cow milk and egg) with micronutrient
supplementation improved linear growth of children aged
<2 y. A randomized controlled trial that evaluates the same
intervention provided for a longer duration with an additional
intervention to reduce pathogen burden with post-intervention
follow-up and appropriate control group(s) is warranted to test
this hypothesis and further assess the durability of the response
to treatment.
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